Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials
- 1 July 2001
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (7) , 998-1017
- https://doi.org/10.1016/s0149-2918(01)80087-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: